- Global Pharma News & Resources

Global Unit Dose Manufacturing Market Analysis Report 2021-2028 by Sourcing (In-house, Outsourcing), Product (Liquid Unit Dose, Solid Unit Dose) -

DUBLIN--(BUSINESS WIRE)--The "Unit Dose Manufacturing Market 2021-2028" report has been added to's offering.

The global unit dose manufacturing market size is expected to reach USD 61.5 billion by 2028 and is expected to expand at a CAGR of 18.2% from 2021 to 2028

In the first half of 2020, the growth of the market was stagnant, but the market started to recover by the end of 2020. It was mainly due to the use of unit doses for the treatment of COVID-19 as it decreases the risk involved while handling and pouring doses from the same bottle.

Unit dose manufacturing has many advantages as the drug can be easily identified, and the formulation of the drug is protected until the moment of administration. If the container is intact and the drug has not been used, it can be redisposed and retrieved without changing its formulation. The most important benefit is that it can be administered in the proper dosage and ensures that the patient does not exceed the prescribed limit.

However, the COVID-19 pandemic has a significant effect on the pharmaceutical market. The first half of the COVID-19 pandemic had slowed growth but by the end of 2020, the market started to recover. The unit dose manufacturing is lucratively used in the current scenario as it reduces the risk of handling and contamination.

Also, unit doses are widely used in hospitals for COVID-19 patients to safeguard both patients and healthcare personnel to eliminate the possibility of viral transmission by airborne transmission or direct touch.

Unit Dose Manufacturing Market Report Highlights

  • By sourcing, the outsourcing segment dominated the market with a revenue share of over 55.0% in 2020. This growth can be attributed to the increased demand by the customers and small pharma companies
  • The solid unit dose product segment held the largest revenue share of over 45.0% in 2020 as it is cost-efficient and simple to use and has a good shelf life
  • The independent pharmacies end-use segment dominated the market with a revenue share of over 30.0% in 2020. This growth can be attributed to the different products offered by this sector
  • The U.S. led the North American market and accounted for a revenue share of over 90.0% in 2020

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

Chapter 3 Unit Dose Manufacturing Market: Variables, Trends, & Scope

3.1 Market Lineage Outlook

3.1.1 Parent market outlook

3.1.2 Ancillary market outlook

3.2 Penetration & Growth Prospect Mapping

3.3 Regulatory Framework

3.3.1 U.S.

3.3.2 Canada

3.4 Market Dynamics

3.4.1 Market Driver Analysis Increased adoption of unit doses Benefits of manufacturing unit doses over repackaging Flourishing pharmaceutical industry

3.4.2 Market Restraint Analysis Challenges associated with the adoption of manufactured unit doses

3.5 Unit Dose Manufacturing Market Analysis Tools

3.5.1 Porter's five forces analysis

3.5.2 PESTEL analysis

3.5.3 Major deals & strategic alliances

3.5.4 COVID Impact

Chapter 4 Unit Dose Manufacturing Market: Sourcing Segment Analysis

4.1 Unit Dose Manufacturing Market: Definition & Scope

4.2 Unit Dose Manufacturing: Market Share Analysis, 2020 & 2028

4.3 In-house

4.4 Outsourcing

Chapter 5 Unit Dose Manufacturing Market: Product Segment Analysis

5.1 Unit Dose Manufacturing Market: Definition & Scope

5.2 Unit Dose Manufacturing: Market Share Analysis, 2020 & 2028

5.3 Liquid Unit Dose Manufacturing

5.4 Solid Unit Dose Manufacturing

Chapter 6 Unit Dose Manufacturing Market: End-use Segment Analysis

6.1 Unit Dose Manufacturing Market: Definition & Scope

6.2 Unit Dose Manufacturing: Market Share Analysis, 2020 & 2028

6.3 Independent Pharmacies

6.4 Long Term Care Facility

6.5 Hospitals

Chapter 7 Unit Dose Manufacturing Market: Regional Analysis

Company Profiles

  • Catalent, Inc.
  • Patheon (Thermo Fisher Scientific Inc.)
  • Unither Pharmaceuticals
  • Mikart
  • TapeMark
  • Renaissance Lakewood, LLC
  • Medical Packaging, Inc.
  • Corden Pharma
  • American Health Packaging

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 06-Jan-2022